Current use of and trends in hematopoietic cell transplantation in the United States A D'Souza, C Fretham, SJ Lee, M Arora, J Brunner, S Chhabra, S Devine, ... Biology of Blood and Marrow Transplantation 26 (8), e177-e182, 2020 | 656 | 2020 |
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 248 | 2017 |
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant … N Ghosh, R Karmali, V Rocha, KW Ahn, A DiGilio, PN Hari, V Bachanova, ... Journal of Clinical Oncology 34 (26), 3141, 2016 | 246 | 2016 |
Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides, 2018 A D’Souza, C Fretham Center for International Blood and Marrow Transplant Research (CIBMTR). http …, 2019 | 234 | 2019 |
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome A D'Souza, SR Hayman, F Buadi, M Mauermann, MQ Lacy, MA Gertz, ... Blood, The Journal of the American Society of Hematology 118 (17), 4663-4665, 2011 | 232 | 2011 |
Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: a Center for International Blood and Marrow Transplant Research Study A D'Souza, A Dispenzieri, B Wirk, MJ Zhang, J Huang, MA Gertz, RA Kyle, ... Journal of Clinical Oncology 33 (32), 3741-3749, 2015 | 208 | 2015 |
Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides A D'Souza, C Fretham Center for International Blood & Marrow Transplant Research. https://www …, 2018 | 182 | 2018 |
Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis B Dhakal, A Szabo, S Chhabra, M Hamadani, A D’Souza, SZ Usmani, ... JAMA oncology 4 (3), 343-350, 2018 | 174 | 2018 |
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma LJ Costa, S Chhabra, E Medvedova, BR Dholaria, TM Schmidt, KN Godby, ... Journal of Clinical Oncology 40 (25), 2901-2912, 2022 | 167 | 2022 |
Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience A D'Souza, M Lacy, M Gertz, S Kumar, F Buadi, S Hayman, D Dingli, ... Blood, The Journal of the American Society of Hematology 120 (1), 56-62, 2012 | 163 | 2012 |
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation TS Fenske, KW Ahn, TM Graff, A DiGilio, Q Bashir, RT Kamble, E Ayala, ... British journal of haematology 174 (2), 235-248, 2016 | 143 | 2016 |
Granulocyte colony–stimulating factor administration: adverse events A D'Souza, I Jaiyesimi, L Trainor, P Venuturumili Transfusion Medicine Reviews 22 (4), 280-290, 2008 | 131 | 2008 |
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation A El‐Jawahri, YB Chen, R Brazauskas, N He, SJ Lee, JM Knight, ... Cancer 123 (10), 1828-1838, 2017 | 96 | 2017 |
Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration A D’Souza, JD Theis, JA Vrana, A Dogan Amyloid 21 (2), 71-75, 2014 | 92 | 2014 |
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report JR Schriber, PN Hari, KW Ahn, M Fei, LJ Costa, MA Kharfan‐Dabaja, ... Cancer 123 (16), 3141-3149, 2017 | 79 | 2017 |
Patient reported outcomes have arrived: a practical overview for clinicians in using patient reported outcomes in oncology R Warsame, A D’Souza Mayo Clinic Proceedings 94 (11), 2291-2301, 2019 | 78 | 2019 |
Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome C Karam, CJ Klein, A Dispenzieri, PJB Dyck, J Mandrekar, A D'Souza, ... Neurology 84 (19), 1981-1987, 2015 | 78 | 2015 |
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time SK Kumar, A Dispenzieri, R Fraser, F Mingwei, G Akpek, R Cornell, ... Leukemia 32 (4), 986-995, 2018 | 74 | 2018 |
Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome A Pardanani, A D'souza, RA Knudson, CA Hanson, RP Ketterling, ... Leukemia 26 (11), 2439-2441, 2012 | 68 | 2012 |
Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature A D'Souza, J Wilson, S Mukherjee, I Jaiyesimi Clinical Lymphoma Myeloma and Leukemia 10 (1), E1-E9, 2010 | 64 | 2010 |